BIIB041 (prolonged-release fampridine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB041 (prolonged-release fampridine), covering 2016-11-04 to 2016-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis [Phase 4]